Jeffrey H. Kordower - Publications

Affiliations: 
Rush University, Chicago, IL, United States 
Area:
Neuroscience Biology

286 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Hiller BM, Marmion DJ, Thompson CA, Elliott NA, Federoff H, Brundin P, Mattis VB, McMahon CW, Kordower JH. Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson's disease. Npj Regenerative Medicine. 7: 24. PMID 35449132 DOI: 10.1038/s41536-022-00221-y  0.811
2022 Killinger BA, Marshall LL, Chatterjee D, Chu Y, Bras J, Guerreiro R, Kordower JH. In situ proximity labeling identifies Lewy pathology molecular interactions in the human brain. Proceedings of the National Academy of Sciences of the United States of America. 119. PMID 35082147 DOI: 10.1073/pnas.2114405119  0.611
2021 Alarcón-Arís D, Pavia-Collado R, Miquel-Rio L, Coppola-Segovia V, Ferrés-Coy A, Ruiz-Bronchal E, Galofré M, Paz V, Campa L, Revilla R, Montefeltro A, Kordower JH, Vila M, Artigas F, Bortolozzi A. Corrigendum to "Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys" [EBioMedicine 2020; 59:102944]. Ebiomedicine. 74: 103731. PMID 34852293 DOI: 10.1016/j.ebiom.2021.103731  0.323
2021 Marmion DJ, Peelaerts W, Kordower JH. A historical review of multiple system atrophy with a critical appraisal of cellular and animal models. Journal of Neural Transmission (Vienna, Austria : 1996). 128: 1507-1527. PMID 34613484 DOI: 10.1007/s00702-021-02419-8  0.796
2021 Chatterjee D, Marmion DJ, McBride JL, Manfredsson FP, Butler D, Messer A, Kordower JH. Enhanced CNS transduction from AAV.PHP.eB infusion into the cisterna magna of older adult rats compared to AAV9. Gene Therapy. PMID 33753910 DOI: 10.1038/s41434-021-00244-y  0.778
2021 Chu Y, Kordower JH. GDNF signaling in subjects with minimal motor deficits and Parkinson's disease. Neurobiology of Disease. 105298. PMID 33684514 DOI: 10.1016/j.nbd.2021.105298  0.323
2020 Wahlberg LU, Emerich DF, Kordower JH, Bell W, Fradet T, Paolone G. Long-term, stable, targeted biodelivery and efficacy of GDNF from encapsulated cells in the rat and Goettingen miniature pig brain. Current Research in Pharmacology and Drug Discovery. 1: 19-29. PMID 34909639 DOI: 10.1016/j.crphar.2020.04.001  0.351
2020 Marmion DJ, Rutkowski AA, Chatterjee D, Hiller BM, Werner MH, Bezard E, Kirik D, McCown T, Gray SJ, Kordower JH. Viral-based rodent and nonhuman primate models of multiple system atrophy: Fidelity to the human disease. Neurobiology of Disease. 105184. PMID 33221532 DOI: 10.1016/j.nbd.2020.105184  0.818
2020 Harms AS, Kordower JH, Sette A, Lindestam Arlehamn CS, Sulzer D, Mach RH. Inflammation in Experimental Models of α-Synucleinopathies. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33009855 DOI: 10.1002/mds.28264  0.301
2020 Hiller BM, Marmion DJ, Gross RM, Thompson CA, Chavez CA, Brundin P, Wakeman DR, McMahon CW, Kordower JH. Mitomycin-C treatment during differentiation of induced pluripotent stem cell-derived dopamine neurons reduces proliferation without compromising survival or function in vivo. Stem Cells Translational Medicine. PMID 32997443 DOI: 10.1002/sctm.20-0014  0.812
2020 Alarcón-Arís D, Pavia-Collado R, Miquel-Rio L, Coppola-Segovia V, Ferrés-Coy A, Ruiz-Bronchal E, Galofré M, Paz V, Campa L, Revilla R, Montefeltro A, Kordower JH, Vila M, Artigas F, Bortolozzi A. Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys. Ebiomedicine. 59: 102944. PMID 32810825 DOI: 10.1016/J.Ebiom.2020.102944  0.457
2020 Gluncic V, Moric M, Chu Y, Hanko V, Li J, Lukić IK, Lukić A, Edassery SL, Kroin JS, Persons AL, Perry P, Kelly L, Shiveley TJ, Nice K, Napier TC, ... Kordower JH, et al. Corrigendum to: In Utero Exposure to Anesthetics Alters Neuronal Migration Pattern in Developing Cerebral Cortex and Causes Postnatal Behavioral Deficits in Rats. Cerebral Cortex (New York, N.Y. : 1991). PMID 32567651 DOI: 10.1093/Cercor/Bhz234  0.374
2020 Jankovic J, Okun MS, Kordower JH. Stem Cells: Scientific and Ethical Quandaries of a Personalized Approach to Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32529662 DOI: 10.1002/Mds.28187  0.363
2020 Barker RA, Bjorklund A, Gash DM, Whone A, Van Laar A, Kordower JH, Bankiewicz K, Kieburtz K, Saarma M, Booms S, Huttunen HJ, Kells A, Fiandaca MS, Stoessl AJ, Eidelberg D, et al. GDNF and Parkinson's Disease: Where Next? A Summary from a Recent Workshop. Journal of Parkinson's Disease. PMID 32508331 DOI: 10.3233/Jpd-202004  0.435
2020 Sellnow RC, Steece-Collier K, Altwal F, Sandoval IM, Kordower JH, Collier TJ, Sortwell CE, West AR, Manfredsson FP. Striatal Nurr1 Facilitates the Dyskinetic State and Exacerbates Levodopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 32238479 DOI: 10.1523/Jneurosci.2936-19.2020  0.433
2020 Chu Y, Bartus RT, Manfredsson FP, Olanow CW, Kordower JH. Long-term post-mortem studies following neurturin gene therapy in patients with advanced Parkinson's disease. Brain : a Journal of Neurology. 143: 960-975. PMID 32203581 DOI: 10.1093/Brain/Awaa020  0.46
2020 Espay AJ, Kalia LV, Gan-Or Z, Williams-Gray CH, Bedard PL, Rowe SM, Morgante F, Fasano A, Stecher B, Kauffman MA, Farrer MJ, Coffey CS, Schwarzschild MA, Sherer T, Postuma RB, ... ... Kordower JH, et al. Disease modification and biomarker development in Parkinson disease: Revision or reconstruction? Neurology. PMID 32102975 DOI: 10.1212/Wnl.0000000000009107  0.425
2020 Williams GP, Marmion DJ, Schonhoff AM, Jurkuvenaite A, Won WJ, Standaert DG, Kordower JH, Harms AS. T cell infiltration in both human multiple system atrophy and a novel mouse model of the disease. Acta Neuropathologica. PMID 31993745 DOI: 10.1007/S00401-020-02126-W  0.794
2020 von Linstow CU, DeLano-Taylor M, Kordower JH, Brundin P. Does Developmental Variability in the Number of Midbrain Dopamine Neurons Affect Individual Risk for Sporadic Parkinson's Disease? Journal of Parkinson's Disease. PMID 31958098 DOI: 10.3233/Jpd-191877  0.458
2019 Song B, Cha Y, Ko S, Jeon J, Lee N, Seo H, Park KJ, Lee IH, Lopes C, Feitosa M, Luna MJ, Jung JH, Kim J, Hwang D, Cohen B, ... ... Kordower JH, et al. Human Autologous iPSC-Derived Dopaminergic Progenitors Restore Motor Function in Parkinson's Disease Models. The Journal of Clinical Investigation. PMID 31714896 DOI: 10.1172/Jci130767  0.475
2019 Chu Y, Muller S, Tavares A, Barret O, Alagille D, Seibyl J, Tamagnan G, Marek K, Luk KC, Trojanowski JQ, Lee VMY, Kordower JH. Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes. Brain : a Journal of Neurology. PMID 31580415 DOI: 10.1093/Brain/Awz296  0.431
2019 Chatterjee D, Kordower JH. Immunotherapy in Parkinson's disease: Current status and future directions. Neurobiology of Disease. 104587. PMID 31454546 DOI: 10.1016/J.Nbd.2019.104587  0.674
2019 Killinger B, Kordower JH. Spreading of alpha-synuclein - relevant or epiphenomenon? Journal of Neurochemistry. PMID 31152606 DOI: 10.1111/Jnc.14779  0.472
2019 LeWitt PA, Lipsman N, Kordower JH. Focused ultrasound opening of the blood-brain barrier for treatment of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31136023 DOI: 10.1002/Mds.27722  0.397
2019 Olanow CW, Savolainen M, Chu Y, Halliday GM, Kordower JH. Temporal evolution of microglia and α-synuclein accumulation following foetal grafting in Parkinson's disease. Brain : a Journal of Neurology. PMID 31056668 DOI: 10.1093/Brain/Awz104  0.406
2019 Mondal S, Rangasamy SB, Roy A, Dasarathy S, Kordower JH, Pahan K. Low-Dose Maraviroc, an Antiretroviral Drug, Attenuates the Infiltration of T Cells into the Central Nervous System and Protects the Nigrostriatum in Hemiparkinsonian Monkeys. Journal of Immunology (Baltimore, Md. : 1950). PMID 31043478 DOI: 10.4049/Jimmunol.1800587  0.398
2019 Emerich DF, Kordower JH, Chu Y, Thanos C, Bintz B, Paolone G, Wahlberg LU. Widespread Striatal Delivery of GDNF from Encapsulated Cells Prevents the Anatomical and Functional Consequences of Excitotoxicity. Neural Plasticity. 2019: 6286197. PMID 30984255 DOI: 10.1155/2019/6286197  0.39
2019 Chatterjee D, Sanchez DS, Quansah E, Rey NL, George S, Becker K, Madaj Z, Steiner JA, Ma J, Escobar Galvis ML, Kordower JH, Brundin P. Loss of One Engrailed1 Allele Enhances Induced α-Synucleinopathy. Journal of Parkinson's Disease. PMID 30932894 DOI: 10.3233/Jpd-191590  0.67
2019 Price RJ, Fisher DG, Suk JS, Hanes J, Ko HS, Kordower JH. Parkinson's disease gene therapy: Will focused ultrasound and nanovectors be the next frontier? Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30908781 DOI: 10.1002/Mds.27675  0.388
2019 Masnata M, Sciacca G, Maxan A, Bousset L, Denis HL, Lauruol F, David L, Saint-Pierre M, Kordower JH, Melki R, Alpaugh M, Cicchetti F. Demonstration of prion-like properties of mutant huntingtin fibrils in both in vitro and in vivo paradigms. Acta Neuropathologica. PMID 30788585 DOI: 10.1007/S00401-019-01973-6  0.387
2019 Dodiya HB, Forsyth CB, Voigt RM, Engen P, Patel J, Shaikh M, Green SJ, Naqib A, Roy A, Kordower JH, Pahan K, Shannon KM, Keshavarzian A. 876 – Stress-Induced Disruption of Intestinal Barrier and Dysbiosis Accelerated Neuroinflammation and Neurodegeneration in a Mouse Model of Parkinson's Disease: Evidence for Gut-Brain Axis Dysfunction in PD Gastroenterology. 156: S-197. DOI: 10.1016/S0016-5085(19)37285-3  0.405
2018 Dodiya HB, Forsyth CB, Voigt RM, Engen PA, Patel J, Shaikh M, Green SJ, Naqib A, Roy A, Kordower JH, Pahan K, Shannon KM, Keshavarzian A. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease. Neurobiology of Disease. PMID 30579705 DOI: 10.1016/J.Nbd.2018.12.012  0.4
2018 Perez-Pardo P, Dodiya HB, Engen PA, Forsyth CB, Huschens AM, Shaikh M, Voigt RM, Naqib A, Green SJ, Kordower JH, Shannon KM, Garssen J, Kraneveld AD, Keshavarzian A. Role of TLR4 in the gut-brain axis in Parkinson's disease: a translational study from men to mice. Gut. PMID 30554160 DOI: 10.1136/Gutjnl-2018-316844  0.394
2018 Chatterjee D, Bhatt M, Butler D, De Genst E, Dobson CM, Messer A, Kordower JH. Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson's disease model. Npj Parkinson's Disease. 4: 25. PMID 30155513 DOI: 10.1038/S41531-018-0062-4  0.757
2018 Savolainen M, Emerich D, Kordower JH. Disease Modification Through Trophic Factor Delivery. Methods in Molecular Biology (Clifton, N.J.). 1780: 525-547. PMID 29856034 DOI: 10.1007/978-1-4939-7825-0_24  0.433
2018 Kordower JH, Burke RE. Disease modification for Parkinson's disease: Axonal regeneration and trophic factors. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29603370 DOI: 10.1002/Mds.27383  0.403
2018 Becker K, Wang X, Vander Stel K, Chu Y, Kordower J, Ma J. Detecting Alpha Synuclein Seeding Activity in Formaldehyde-Fixed MSA Patient Tissue by PMCA. Molecular Neurobiology. PMID 29589283 DOI: 10.1007/S12035-018-1007-Y  0.329
2018 Marshall MS, Jakubauskas B, Bogue W, Stoskute M, Hauck Z, Rue E, Nichols M, DiAntonio LL, van Breemen RB, Kordower JH, Saavedra-Matiz CA, Bongarzone ER. Analysis of age-related changes in psychosine metabolism in the human brain. Plos One. 13: e0193438. PMID 29481565 DOI: 10.1371/Journal.Pone.0193438  0.397
2018 Chu Y, Buchman AS, Olanow CW, Kordower JH. Do subjects with minimal motor features have prodromal PD? Annals of Neurology. PMID 29420861 DOI: 10.1002/Ana.25179  0.38
2018 Pal G, Ouyang B, Verhagen L, Serrano G, Shill HA, Adler CH, Beach TG, Kordower JH. Probing the striatal dopamine system for a putative neuroprotective effect of deep brain stimulation in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29380902 DOI: 10.1002/Mds.27280  0.387
2018 Manfredsson FP, Luk KC, Benskey MJ, Guezer A, Garcia J, Kuhn NC, Sandoval IM, Patterson JR, O'Mara A, Yonkers R, Kordower JH. Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology. Neurobiology of Disease. PMID 29341898 DOI: 10.1016/J.Nbd.2018.01.008  0.451
2018 Patrick Flavin W, Freeman D, Bousset L, Green Z, Chu Y, Kordower J, Melki R, Campbell E. Propagating prion-like amyloid proteins invade target cells through endocytic vesicle rupture Neurology. 91: S26.3-S26. DOI: 10.1212/01.Wnl.0000550682.38963.90  0.372
2017 Cisbani G, Maxan A, Kordower JH, Planel E, Freeman TB, Cicchetti F. Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's disease. Brain : a Journal of Neurology. 140: 2982-2992. PMID 29069396 DOI: 10.1093/Brain/Awx255  0.399
2017 Brundin P, Dave KD, Kordower JH. Therapeutic approaches to target alpha-synuclein pathology. Experimental Neurology. PMID 28987463 DOI: 10.1016/J.Expneurol.2017.10.003  0.344
2017 Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, ... ... Kordower JH, et al. Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy. Movement Disorders : Official Journal of the Movement Disorder Society. 32: 1264-1310. PMID 28887905 DOI: 10.1002/Mds.27115  0.402
2017 Mandel RJ, Marmion DJ, Kirik D, Chu Y, Heindel C, McCown T, Gray SJ, Kordower JH. Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates. Acta Neuropathologica Communications. 5: 47. PMID 28619074 DOI: 10.1186/S40478-017-0451-7  0.811
2017 Wakeman DR, Hiller BM, Marmion DJ, McMahon CW, Corbett GT, Mangan KP, Ma J, Little LE, Xie Z, Perez-Rosello T, Guzman JN, Surmeier DJ, Kordower JH. Cryopreservation Maintains Functionality of Human iPSC Dopamine Neurons and Rescues Parkinsonian Phenotypes In Vivo. Stem Cell Reports. PMID 28579395 DOI: 10.1016/J.Stemcr.2017.04.033  0.828
2017 Flavin WP, Bousset L, Green ZC, Chu Y, Skarpathiotis S, Chaney MJ, Kordower JH, Melki R, Campbell EM. Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteins. Acta Neuropathologica. PMID 28527044 DOI: 10.1007/S00401-017-1722-X  0.368
2017 Collier TJ, Kanaan NM, Kordower JH. Aging and Parkinson's disease: Different sides of the same coin? Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28520211 DOI: 10.1002/Mds.27037  0.437
2017 Marmion DJ, Kordower JH. α-Synuclein nonhuman primate models of Parkinson's disease. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 28434076 DOI: 10.1007/S00702-017-1720-0  0.81
2017 Kordower JH. What would Dr. James Parkinson think today? parcelling out the circuitry of levodopa-induced dyskinesias. Movement Disorders : Official Journal of the Movement Disorder Society. 32: 483-484. PMID 28425143 DOI: 10.1002/Mds.27024  0.399
2017 Engen PA, Dodiya HB, Naqib A, Forsyth CB, Green SJ, Voigt RM, Kordower JH, Mutlu EA, Shannon KM, Keshavarzian A. The Potential Role of Gut-Derived Inflammation in Multiple System Atrophy. Journal of Parkinson's Disease. PMID 28234259 DOI: 10.3233/Jpd-160991  0.346
2017 Olanow CW, Kordower JH. Targeting α-Synuclein as a therapy for Parkinson's disease: The battle begins. Movement Disorders : Official Journal of the Movement Disorder Society. 32: 203-207. PMID 28218461 DOI: 10.1002/Mds.26935  0.398
2017 Lee JM, Derkinderen P, Kordower JH, Freeman R, Munoz DG, Kremer T, Zago W, Hutten SJ, Adler CH, Serrano GE, Beach TG. The Search for a Peripheral Biopsy Indicator of α-Synuclein Pathology for Parkinson Disease. Journal of Neuropathology and Experimental Neurology. PMID 28069931 DOI: 10.1093/Jnen/Nlw103  0.394
2017 Kordower JH. SPREADING OF PATHOLOGY IN PARKINSON'S DISEASE Alzheimer's & Dementia. 13: P877. DOI: 10.1016/J.Jalz.2017.07.261  0.41
2016 Ghosh A, Tyson T, George S, Hildebrandt EN, Steiner JA, Madaj Z, Schulz E, Machiela E, McDonald WG, Escobar Galvis ML, Kordower JH, Van Raamsdonk JM, Colca JR, Brundin P. Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson's disease. Science Translational Medicine. 8: 368ra174. PMID 27928028 DOI: 10.1126/Scitranslmed.Aag2210  0.454
2016 Kordower JH, Goetz CG, Chu Y, Halliday GM, Nicholson DA, Musial T, Marmion DJ, Stoessl AJ, Sossi V, Freeman TB, Olanow CW. Robust graft survival and normalized dopaminergic innervation does not obligate recovery in a pd patient. Annals of Neurology. PMID 27900791 DOI: 10.1002/Ana.24820  0.802
2016 Beach TG, Corbillé AG, Letournel F, Kordower JH, Kremer T, Munoz DG, Intorcia A, Hentz J, Adler CH, Sue LI, Walker J, Serrano G, Derkinderen P. Multicenter Assessment of Immunohistochemical Methods for Pathological Alpha-Synuclein in Sigmoid Colon of Autopsied Parkinson's Disease and Control Subjects. Journal of Parkinson's Disease. PMID 27589538 DOI: 10.3233/Jpd-160888  0.379
2016 Kurowska Z, Kordower JH, Stoessl AJ, Burke R, Brundin P, Yue Z, Brady ST, Milbrandt J, Trapp BD, Sherer TB, Medicetty S. Is Axonal Degeneration a Key Early Event in Parkinson's Disease? Journal of Parkinson's Disease. PMID 27497486 DOI: 10.3233/Jpd-160881  0.375
2016 Kordower JH, Vinuela A, Chu Y, Isacson O, Redmond DE. Parkinsonian Monkeys With Prior Levodopa-Induced Dyskinesias Followed by Fetal Dopamine Precursor Grafts Do Not Display Graft-Induced Dyskinesias. The Journal of Comparative Neurology. PMID 27418401 DOI: 10.1002/Cne.24081  0.386
2016 Brundin P, Ma J, Kordower JH. How strong is the evidence that Parkinson's disease is a prion disorder? Current Opinion in Neurology. PMID 27257944 DOI: 10.1097/Wco.0000000000000349  0.413
2016 Kordower JH, Olanow CW. Fetal grafts for Parkinson's disease: Decades in the making. Proceedings of the National Academy of Sciences of the United States of America. PMID 27247420 DOI: 10.1073/Pnas.1606342113  0.447
2016 Chandra G, Rangasamy SB, Roy A, Kordower JH, Pahan K. Neutralization of regulated on activation, normal T cell expressed and secreted and eotaxin prevents the loss of dopaminergic neurons in a mouse model of Parkinson's disease. The Journal of Biological Chemistry. PMID 27226559 DOI: 10.1074/Jbc.M116.714824  0.465
2016 Corbillé AG, Letournel F, Kordower JH, Lee J, Shanes E, Neunlist M, Munoz DG, Derkinderen P, Beach TG. Evaluation of alpha-synuclein immunohistochemical methods for the detection of Lewy-type synucleinopathy in gastrointestinal biopsies. Acta Neuropathologica Communications. 4: 35. PMID 27044604 DOI: 10.1186/S40478-016-0305-8  0.338
2016 Chu Y, Morfini GA, Kordower JH. Alterations in Activity-Dependent Neuroprotective Protein in Sporadic and Experimental Parkinson's Disease. Journal of Parkinson's Disease. PMID 27003787 DOI: 10.3233/Jpd-160812  0.42
2016 Kordower JH. AAV2-Neurturin for Parkinson's Disease: What Lessons Have We Learned? Methods in Molecular Biology (Clifton, N.J.). 1382: 485-90. PMID 26611606 DOI: 10.1007/978-1-4939-3271-9_32  0.385
2015 Fung VS, Kordower JH. Parkinson's disease and prion disease: Straining the comparison. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1727. PMID 26769458 DOI: 10.1002/Mds.26437  0.356
2015 Olanow CW, Bartus RT, Volpicelli-Daley LA, Kordower JH. Trophic factors for Parkinson's disease: To live or let die. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1715-24. PMID 26769457 DOI: 10.1002/Mds.26426  0.38
2015 Keiser MS, Kordower JH, Gonzalez-Alegre P, Davidson BL. Broad distribution of ataxin 1 silencing in rhesus cerebella for spinocerebellar ataxia type 1 therapy. Brain : a Journal of Neurology. PMID 26490326 DOI: 10.1093/Brain/Awv292  0.551
2015 Dehay B, Vila M, Bezard E, Brundin P, Kordower JH. Alpha-synuclein propagation: New insights from animal models. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26347034 DOI: 10.1002/Mds.26370  0.371
2015 Su X, Chu Y, Kordower JH, Li B, Cao H, Huang L, Nishida M, Song L, Wang D, Federoff HJ. PGC-1α Promoter Methylation in Parkinson's Disease. Plos One. 10: e0134087. PMID 26317511 DOI: 10.1371/Journal.Pone.0134087  0.358
2015 Gatto RG, Chu Y, Ye AQ, Price SD, Tavassoli E, Buenaventura A, Brady ST, Magin RL, Kordower JH, Morfini GA. Analysis of YFP(J16)-R6/2 reporter mice and postmortem brains reveals early pathology and increased vulnerability of callosal axons in Huntington's disease. Human Molecular Genetics. 24: 5285-98. PMID 26123489 DOI: 10.1093/Hmg/Ddv248  0.354
2015 Warren Olanow C, Bartus RT, Baumann TL, Factor S, Boulis N, Stacy M, Turner DA, Marks W, Larson P, Starr PA, Jankovic J, Simpson R, Watts R, Guthrie B, Poston K, ... ... Kordower JH, et al. Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial. Annals of Neurology. 78: 248-57. PMID 26061140 DOI: 10.1002/Ana.24436  0.346
2015 Chu Y, Kordower JH. The prion hypothesis of Parkinson's disease. Current Neurology and Neuroscience Reports. 15: 28. PMID 25868519 DOI: 10.1007/S11910-015-0549-X  0.418
2015 Bartus RT, Kordower JH, Johnson EM, Brown L, Kruegel BR, Chu Y, Baumann TL, Lang AE, Olanow CW, Herzog CD. Post-mortem assessment of the short and long-term effects of the trophic factor neurturin in patients with α-synucleinopathies. Neurobiology of Disease. 78: 162-71. PMID 25841760 DOI: 10.1016/J.Nbd.2015.03.023  0.436
2015 Roy A, Mondal S, Kordower JH, Pahan K. Attenuation of microglial RANTES by NEMO-binding domain peptide inhibits the infiltration of CD8(+) T cells in the nigra of hemiparkinsonian monkey. Neuroscience. PMID 25783477 DOI: 10.1016/J.Neuroscience.2015.03.011  0.368
2015 Kordower JH. Gene therapy for Parkinson's disease: still a hot topic? Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 255-6. PMID 25482182 DOI: 10.1038/Npp.2014.235  0.424
2014 Olanow CW, Wakeman DR, Kordower JH. Peripheral alpha-synuclein and Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 963-6. PMID 25043799 DOI: 10.1002/Mds.25966  0.465
2014 Kordower JH, Halliday G. Misfolded proteins in Huntington disease fetal grafts: further evidence of cell-to-cell transfer? Annals of Neurology. 76: 20-1. PMID 24961209 DOI: 10.1002/Ana.24205  0.332
2014 Kelly LP, Carvey PM, Keshavarzian A, Shannon KM, Shaikh M, Bakay RA, Kordower JH. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 999-1009. PMID 24898698 DOI: 10.1002/Mds.25736  0.779
2014 Kordower JH. The prion hypothesis of Parkinson's disease: this hot topic just got hotter. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 988. PMID 24867814 DOI: 10.1002/Mds.25918  0.4
2014 Chu Y, Goldman JG, Kelly L, He Y, Waliczek T, Kordower JH. Abnormal alpha-synuclein reduces nigral voltage-dependent anion channel 1 in sporadic and experimental Parkinson's disease. Neurobiology of Disease. 69: 1-14. PMID 24825319 DOI: 10.1016/J.Nbd.2014.05.003  0.783
2014 Mattis VB, Wakeman DR, Tom C, Dodiya HB, Yeung SY, Tran AH, Bernau K, Ornelas L, Sahabian A, Reidling J, Sareen D, Thompson LM, Kordower JH, Svendsen CN. Neonatal immune-tolerance in mice does not prevent xenograft rejection. Experimental Neurology. 254: 90-8. PMID 24440640 DOI: 10.1016/J.Expneurol.2014.01.007  0.325
2014 Rafii MS, Baumann TL, Bakay RA, Ostrove JM, Siffert J, Fleisher AS, Herzog CD, Barba D, Pay M, Salmon DP, Chu Y, Kordower JH, Bishop K, Keator D, Potkin S, et al. A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 571-81. PMID 24411134 DOI: 10.1016/J.Jalz.2013.09.004  0.373
2013 Bhatt MA, Messer A, Kordower JH. Can intrabodies serve as neuroprotective therapies for Parkinson's disease? Beginning thoughts. Journal of Parkinson's Disease. 3: 581-91. PMID 24270241 DOI: 10.3233/Jpd-130252  0.628
2013 Roy A, Jana M, Corbett GT, Ramaswamy S, Kordower JH, Gonzalez FJ, Pahan K. Regulation of cyclic AMP response element binding and hippocampal plasticity-related genes by peroxisome proliferator-activated receptor α. Cell Reports. 4: 724-37. PMID 23972989 DOI: 10.1016/J.Celrep.2013.07.028  0.549
2013 Kordower JH, Olanow CW, Dodiya HB, Chu Y, Beach TG, Adler CH, Halliday GM, Bartus RT. Disease duration and the integrity of the nigrostriatal system in Parkinson's disease. Brain : a Journal of Neurology. 136: 2419-31. PMID 23884810 DOI: 10.1093/Brain/Awt192  0.454
2013 Cederfjäll E, Nilsson N, Sahin G, Chu Y, Nikitidou E, Björklund T, Kordower JH, Kirik D. Continuous DOPA synthesis from a single AAV: dosing and efficacy in models of Parkinson's disease. Scientific Reports. 3: 2157. PMID 23831692 DOI: 10.1038/Srep02157  0.358
2013 Bjorklund A, Kordower JH. Cell therapy for Parkinson's disease: what next? Movement Disorders : Official Journal of the Movement Disorder Society. 28: 110-5. PMID 23390097 DOI: 10.1002/Mds.25343  0.464
2013 Kordower JH, Bjorklund A. Trophic factor gene therapy for Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 96-109. PMID 23390096 DOI: 10.1002/Mds.25344  0.445
2012 Brundin P, Kordower JH. Neuropathology in transplants in Parkinson's disease: implications for disease pathogenesis and the future of cell therapy. Progress in Brain Research. 200: 221-41. PMID 23195421 DOI: 10.1016/B978-0-444-59575-1.00010-7  0.496
2012 Wayman WN, Dodiya HB, Persons AL, Kashanchi F, Kordower JH, Hu XT, Napier TC. Enduring cortical alterations after a single in-vivo treatment of HIV-1 Tat. Neuroreport. 23: 825-9. PMID 22828409 DOI: 10.1097/Wnr.0B013E3283578050  0.334
2012 Chu Y, Morfini GA, Langhamer LB, He Y, Brady ST, Kordower JH. Alterations in axonal transport motor proteins in sporadic and experimental Parkinson's disease. Brain : a Journal of Neurology. 135: 2058-73. PMID 22719003 DOI: 10.1093/Brain/Aws133  0.427
2012 Mondal S, Roy A, Jana A, Ghosh S, Kordower JH, Pahan K. Testing NF-κB-based therapy in hemiparkinsonian monkeys. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 7: 544-56. PMID 22661311 DOI: 10.1007/S11481-012-9377-9  0.392
2012 Shannon KM, Keshavarzian A, Dodiya HB, Jakate S, Kordower JH. Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 716-9. PMID 22550057 DOI: 10.1002/Mds.25020  0.416
2012 Ramaswamy S, Kordower JH. Gene therapy for Huntington's disease. Neurobiology of Disease. 48: 243-54. PMID 22222669 DOI: 10.1016/J.Nbd.2011.12.030  0.632
2012 Shannon KM, Keshavarzian A, Mutlu E, Dodiya HB, Daian D, Jaglin JA, Kordower JH. Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 709-15. PMID 21766334 DOI: 10.1002/Mds.23838  0.422
2011 Herzog CD, Bishop KM, Brown L, Wilson A, Kordower JH, Bartus RT. Gene transfer provides a practical means for safe, long-term, targeted delivery of biologically active neurotrophic factor proteins for neurodegenerative diseases. Drug Delivery and Translational Research. 1: 361-82. PMID 25788422 DOI: 10.1007/S13346-011-0037-Z  0.459
2011 Forsyth CB, Shannon KM, Kordower JH, Voigt RM, Shaikh M, Jaglin JA, Estes JD, Dodiya HB, Keshavarzian A. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease. Plos One. 6: e28032. PMID 22145021 DOI: 10.1371/Journal.Pone.0028032  0.374
2011 Kriks S, Shim JW, Piao J, Ganat YM, Wakeman DR, Xie Z, Carrillo-Reid L, Auyeung G, Antonacci C, Buch A, Yang L, Beal MF, Surmeier DJ, Kordower JH, Tabar V, et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature. 480: 547-51. PMID 22056989 DOI: 10.1038/Nature10648  0.489
2011 Mickiewicz AL, Kordower JH. GDNF family ligands: a potential future for Parkinson's disease therapy. Cns & Neurological Disorders Drug Targets. 10: 703-11. PMID 21838676 DOI: 10.2174/187152711797247876  0.493
2011 Bartus RT, Brown L, Wilson A, Kruegel B, Siffert J, Johnson EM, Kordower JH, Herzog CD. Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: support for nigral targeting in Parkinson's disease. Neurobiology of Disease. 44: 38-52. PMID 21704161 DOI: 10.1016/J.Nbd.2011.05.026  0.374
2011 Kordower JH, Dodiya HB, Kordower AM, Terpstra B, Paumier K, Madhavan L, Sortwell C, Steece-Collier K, Collier TJ. Transfer of host-derived α synuclein to grafted dopaminergic neurons in rat. Neurobiology of Disease. 43: 552-7. PMID 21600984 DOI: 10.1016/J.Nbd.2011.05.001  0.435
2011 Collier TJ, Kanaan NM, Kordower JH. Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates. Nature Reviews. Neuroscience. 12: 359-66. PMID 21587290 DOI: 10.1038/Nrn3039  0.446
2011 Bartus RT, Herzog CD, Chu Y, Wilson A, Brown L, Siffert J, Johnson EM, Olanow CW, Mufson EJ, Kordower JH. Bioactivity of AAV2-neurturin gene therapy (CERE-120): differences between Parkinson's disease and nonhuman primate brains. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 27-36. PMID 21322017 DOI: 10.1002/Mds.23442  0.5
2011 Wakeman DR, Dodiya HB, Kordower JH. Cell transplantation and gene therapy in Parkinson's disease. The Mount Sinai Journal of Medicine, New York. 78: 126-58. PMID 21259269 DOI: 10.1002/Msj.20233  0.475
2011 Chu Y, Mickiewicz AL, Kordower JH. α-synuclein aggregation reduces nigral myocyte enhancer factor-2D in idiopathic and experimental Parkinson's disease. Neurobiology of Disease. 41: 71-82. PMID 20816781 DOI: 10.1016/J.Nbd.2010.08.022  0.479
2011 Soderstrom KE, Ramaswamy S, Olanow CW, Kordower JH. Animal Models of Parkinson's Disease: The Non-Motor and Non-Dopaminergic Features Parkinson's Disease: Non-Motor and Non-Dopaminergic Features. 79-92. DOI: 10.1002/9781444397970.ch7  0.589
2010 Dodiya HB, Bjorklund T, Stansell Iii J, Mandel RJ, Kirik D, Kordower JH. Differential Transduction Following Basal Ganglia Administration of Distinct Pseudotyped AAV Capsid Serotypes in Nonhuman Primates. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 579-587. PMID 28182881 DOI: 10.1038/mt.2009.216  0.342
2010 Marks WJ, Bartus RT, Siffert J, Davis CS, Lozano A, Boulis N, Vitek J, Stacy M, Turner D, Verhagen L, Bakay R, Watts R, Guthrie B, Jankovic J, Simpson R, ... ... Kordower JH, et al. Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial. The Lancet. Neurology. 9: 1164-72. PMID 20970382 DOI: 10.1016/S1474-4422(10)70254-4  0.358
2010 Rangasamy SB, Soderstrom K, Bakay RA, Kordower JH. Neurotrophic factor therapy for Parkinson's disease. Progress in Brain Research. 184: 237-64. PMID 20887879 DOI: 10.1016/S0079-6123(10)84013-0  0.468
2010 Cai Y, Xiong K, Zhang XM, Cai H, Luo XG, Feng JC, Clough RW, Struble RG, Patrylo PR, Chu Y, Kordower JH, Yan XX. β-Secretase-1 elevation in aged monkey and Alzheimer's disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and β-amyloid accumulation. The European Journal of Neuroscience. 32: 1223-38. PMID 20726888 DOI: 10.1111/J.1460-9568.2010.07376.X  0.322
2010 Obeso JA, Rodriguez-Oroz MC, Goetz CG, Marin C, Kordower JH, Rodriguez M, Hirsch EC, Farrer M, Schapira AH, Halliday G. Missing pieces in the Parkinson's disease puzzle. Nature Medicine. 16: 653-61. PMID 20495568 DOI: 10.1038/Nm.2165  0.401
2010 Kordower JH, Chen EY, Morrison JH. Long-term gonadal hormone treatment and endogenous neurogenesis in the dentate gyrus of the adult female monkey. Experimental Neurology. 224: 252-7. PMID 20362573 DOI: 10.1016/J.Expneurol.2010.03.027  0.309
2010 Han I, You Y, Kordower JH, Brady ST, Morfini GA. Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features. Journal of Neurochemistry. 113: 1073-91. PMID 20236390 DOI: 10.1111/J.1471-4159.2010.06672.X  0.442
2010 Bjorklund T, Kordower JH. Gene therapy for Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: S161-73. PMID 20187249 DOI: 10.1002/Mds.22785  0.439
2010 Chu Y, Kordower JH. Lewy body pathology in fetal grafts. Annals of the New York Academy of Sciences. 1184: 55-67. PMID 20146690 DOI: 10.1111/J.1749-6632.2009.05229.X  0.436
2010 Dodiya HB, Bjorklund T, Stansell J, Mandel RJ, Kirik D, Kordower JH. Differential transduction following basal ganglia administration of distinct pseudotyped AAV capsid serotypes in nonhuman primates. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 579-87. PMID 19773746 DOI: 10.1038/Mt.2009.216  0.45
2010 Emerich DF, Mooney DJ, Storrie H, Babu RS, Kordower JH. Injectable hydrogels providing sustained delivery of vascular endothelial growth factor are neuroprotective in a rat model of Huntington's disease. Neurotoxicity Research. 17: 66-74. PMID 19588214 DOI: 10.1007/S12640-009-9079-0  0.407
2010 Kanaan NM, Kordower JH, Collier TJ. Age-related changes in glial cells of dopamine midbrain subregions in rhesus monkeys. Neurobiology of Aging. 31: 937-52. PMID 18715678 DOI: 10.1016/J.Neurobiolaging.2008.07.006  0.412
2010 Kirik D, Björklund MT, Ramaswamy S, Kordower JH. Novel Gene-Based Therapeutics Targeting the Dopaminergic System in Parkinson's Disease Dopamine Handbook. DOI: 10.1093/acprof:oso/9780195373035.003.0034  0.6
2010 Chen EY, Fox D, Kordower JH. Neurotrophic factor therapy: GDNF and CNTF Encyclopedia of Neuroscience. 1085-1092. DOI: 10.1016/B978-008045046-9.00015-2  0.3
2009 Ramaswamy S, Kordower JH. Are growth factors the answer? Parkinsonism & Related Disorders. 15: S176-80. PMID 20082985 DOI: 10.1016/S1353-8020(09)70809-0  0.641
2009 Olanow CW, Kordower JH, Lang AE, Obeso JA. Dopaminergic transplantation for Parkinson's disease: current status and future prospects. Annals of Neurology. 66: 591-6. PMID 19938101 DOI: 10.1002/Ana.21778  0.476
2009 Zhang XM, Cai Y, Chu Y, Chen EY, Feng JC, Luo XG, Xiong K, Struble RG, Clough RW, Patrylo PR, Kordower JH, Yan XX. Doublecortin-expressing cells persist in the associative cerebral cortex and amygdala in aged nonhuman primates. Frontiers in Neuroanatomy. 3: 17. PMID 19862344 DOI: 10.3389/Neuro.05.017.2009  0.326
2009 Olanow CW, Kordower JH. Modeling Parkinson's disease. Annals of Neurology. 66: 432-6. PMID 19847894 DOI: 10.1002/Ana.21832  0.405
2009 Mak SK, McCormack AL, Langston JW, Kordower JH, Di Monte DA. Decreased alpha-synuclein expression in the aging mouse substantia nigra. Experimental Neurology. 220: 359-65. PMID 19800328 DOI: 10.1016/J.Expneurol.2009.09.021  0.323
2009 Kordower JH, Brundin P. Propagation of host disease to grafted neurons: accumulating evidence. Experimental Neurology. 220: 224-5. PMID 19786018 DOI: 10.1016/J.Expneurol.2009.09.016  0.387
2009 Ramaswamy S, Soderstrom KE, Kordower JH. Trophic factors therapy in Parkinson's disease. Progress in Brain Research. 175: 201-16. PMID 19660658 DOI: 10.1016/S0079-6123(09)17514-3  0.654
2009 Emborg ME, Moirano J, Raschke J, Bondarenko V, Zufferey R, Peng S, Ebert AD, Joers V, Roitberg B, Holden JE, Koprich J, Lipton J, Kordower JH, Aebischer P. Response of aged parkinsonian monkeys to in vivo gene transfer of GDNF. Neurobiology of Disease. 36: 303-11. PMID 19660547 DOI: 10.1016/J.Nbd.2009.07.022  0.38
2009 Cicchetti F, Saporta S, Hauser RA, Parent M, Saint-Pierre M, Sanberg PR, Li XJ, Parker JR, Chu Y, Mufson EJ, Kordower JH, Freeman TB. Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration. Proceedings of the National Academy of Sciences of the United States of America. 106: 12483-8. PMID 19620721 DOI: 10.1073/Pnas.0904239106  0.433
2009 Chu Y, Dodiya H, Aebischer P, Olanow CW, Kordower JH. Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions. Neurobiology of Disease. 35: 385-98. PMID 19505575 DOI: 10.1016/J.Nbd.2009.05.023  0.425
2009 Herzog CD, Brown L, Gammon D, Kruegel B, Lin R, Wilson A, Bolton A, Printz M, Gasmi M, Bishop KM, Kordower JH, Bartus RT. Expression, bioactivity, and safety 1 year after adeno-associated viral vector type 2-mediated delivery of neurturin to the monkey nigrostriatal system support cere-120 for Parkinson's disease. Neurosurgery. 64: 602-12; discussion 6. PMID 19349823 DOI: 10.1227/01.Neu.0000340682.06068.01  0.488
2009 Cai Y, Xiong K, Chu Y, Luo DW, Luo XG, Yuan XY, Struble RG, Clough RW, Spencer DD, Williamson A, Kordower JH, Patrylo PR, Yan XX. Doublecortin expression in adult cat and primate cerebral cortex relates to immature neurons that develop into GABAergic subgroups. Experimental Neurology. 216: 342-56. PMID 19166833 DOI: 10.1016/J.Expneurol.2008.12.008  0.343
2009 Ramaswamy S, McBride JL, Han I, Berry-Kravis EM, Zhou L, Herzog CD, Gasmi M, Bartus RT, Kordower JH. Intrastriatal CERE-120 (AAV-Neurturin) protects striatal and cortical neurons and delays motor deficits in a transgenic mouse model of Huntington's disease. Neurobiology of Disease. 34: 40-50. PMID 19150499 DOI: 10.1016/J.Nbd.2008.12.005  0.739
2009 Kordower JH, Brundin P. Lewy body pathology in long-term fetal nigral transplants: is Parkinson's disease transmitted from one neural system to another? Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 254. PMID 19079079 DOI: 10.1038/Npp.2008.161  0.366
2009 Olanow CW, Gracies JM, Goetz CG, Stoessl AJ, Freeman T, Kordower JH, Godbold J, Obeso JA. Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: a double blind video-based analysis. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 336-43. PMID 19006186 DOI: 10.1002/Mds.22208  0.327
2009 Marks W, Bartus R, Siffert J, Starr P, Ostrem J, Stacy M, Boulis N, Vitek J, Verhagen L, Watts R, Jankovic J, Tagliati M, Stern M, Nutt J, Kordower J, et al. P2.113 Multicenter, randomized, double-blind, sham surgery-controlled study of intraputaminal AAV2-neurturin (CERE-120) for advanced Parkinson's disease (PD) Parkinsonism & Related Disorders. 15: S120. DOI: 10.1016/S1353-8020(09)70464-X  0.381
2009 Bartus R, Herzog C, Bishop K, Chu Y, Mufson E, Kordower J. P2.112 Bioactivity of CERE-120 (AAV2-neurturin gene therapy) in advanced Parkinson's disease (PD): post-mortem analysis of two autopsy cases Parkinsonism & Related Disorders. 15: S119. DOI: 10.1016/S1353-8020(09)70463-8  0.411
2009 Cicchetti F, Saporta S, Hauser R, Parent M, Saint-Pierre M, Sanberg P, Li X, Parker J, Chu Y, Mufson E, Kordower J, Freeman T. P1.016 Neural transplants in patients with Huntington's disease undergo disease-speciflc neuronal degeneration Parkinsonism & Related Disorders. 15: S33. DOI: 10.1016/S1353-8020(09)70138-5  0.409
2009 Kordower JH. Special issue on neural repair The Journal of Comparative Neurology. 515: spc1-spc1. DOI: 10.1002/Cne.22089  0.311
2008 Isacson O, Kordower JH. Future of cell and gene therapies for Parkinson's disease. Annals of Neurology. 64: S122-38. PMID 19127583 DOI: 10.1002/Ana.21473  0.457
2008 Kordower JH, Chu Y, Hauser RA, Olanow CW, Freeman TB. Transplanted dopaminergic neurons develop PD pathologic changes: a second case report. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 2303-6. PMID 19006193 DOI: 10.1002/Mds.22369  0.463
2008 Herzog CD, Dass B, Gasmi M, Bakay R, Stansell JE, Tuszynski M, Bankiewicz K, Chen EY, Chu Y, Bishop K, Kordower JH, Bartus RT. Transgene expression, bioactivity, and safety of CERE-120 (AAV2-neurturin) following delivery to the monkey striatum. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1737-44. PMID 18728639 DOI: 10.1038/Mt.2008.170  0.441
2008 Kanaan NM, Kordower JH, Collier TJ. Age-related changes in dopamine transporters and accumulation of 3-nitrotyrosine in rhesus monkey midbrain dopamine neurons: relevance in selective neuronal vulnerability to degeneration. The European Journal of Neuroscience. 27: 3205-15. PMID 18598263 DOI: 10.1111/J.1460-9568.2008.06307.X  0.413
2008 Kanaan NM, Kordower JH, Collier TJ. Age and region-specific responses of microglia, but not astrocytes, suggest a role in selective vulnerability of dopamine neurons after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure in monkeys. Glia. 56: 1199-214. PMID 18484101 DOI: 10.1002/Glia.20690  0.417
2008 Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nature Medicine. 14: 504-6. PMID 18391962 DOI: 10.1038/Nm1747  0.486
2008 Redmond DE, Vinuela A, Kordower JH, Isacson O. Influence of cell preparation and target location on the behavioral recovery after striatal transplantation of fetal dopaminergic neurons in a primate model of Parkinson's disease. Neurobiology of Disease. 29: 103-16. PMID 17920901 DOI: 10.1016/J.Nbd.2007.08.008  0.466
2008 Kordower JH, Olanow CW. Regulatable promoters and gene therapy for Parkinson's disease: is the only thing to fear, fear itself? Experimental Neurology. 209: 34-40. PMID 17888424 DOI: 10.1016/J.Expneurol.2007.08.001  0.403
2008 Freeman TB, Chu Y, Hauser R, Olanow W, Kordower JH. Parkinsonʼs Disease Pathology in Nigral Grafts 14 Years after Transplantation Neurosurgery. 62: 1421-1422. DOI: 10.1227/01.Neu.0000333520.01291.7A  0.309
2008 Xiong K, Chu YP, Clough RW, Cai HB, Luo XG, Struble RG, Kordower JH, Yan XX. β-secretase-1 (BACE1) expression in cerebral neocortex shows a modular distribution pattern: Inverse correlation with endogenous neuronal activity Cell Biology International. 32: S10-S11. DOI: 10.1016/J.Cellbi.2008.01.052  0.3
2008 Ramaswamy S, Kordower JH. Gene and cellular transplantation therapies for huntington's disease Cns Regeneration. 267-294. DOI: 10.1016/B978-012373994-0.50013-0  0.593
2008 Chu Y, Kordower JH. The use of Aged Monkeys to Study PD: Important Roles in Pathogenesis and Experimental Therapeutics Parkinson's Disease. 77-85. DOI: 10.1016/B978-0-12-374028-1.00007-5  0.312
2007 Dass B, Kordower JH. Gene therapy approaches for the treatment of Parkinson's disease. Handbook of Clinical Neurology. 84: 291-304. PMID 18808954 DOI: 10.1016/S0072-9752(07)84045-0  0.402
2007 Bartus RT, Herzog CD, Bishop K, Ostrove JM, Tuszynski M, Kordower JH, Gasmi M. Issues regarding gene therapy products for Parkinson's disease: the development of CERE-120 (AAV-NTN) as one reference point. Parkinsonism & Related Disorders. 13: S469-77. PMID 18267286 DOI: 10.1016/S1353-8020(08)70052-X  0.465
2007 Ghosh A, Roy A, Liu X, Kordower JH, Mufson EJ, Hartley DM, Ghosh S, Mosley RL, Gendelman HE, Pahan K. Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America. 104: 18754-9. PMID 18000063 DOI: 10.1073/Pnas.0704908104  0.4
2007 Sani S, Jobe K, Smith A, Kordower JH, Bakay RA. Deep brain stimulation for treatment of obesity in rats. Journal of Neurosurgery. 107: 809-13. PMID 17937228 DOI: 10.3171/Jns-07/10/0809  0.314
2007 Ramaswamy S, McBride JL, Kordower JH. Animal models of Huntington's disease. Ilar Journal / National Research Council, Institute of Laboratory Animal Resources. 48: 356-73. PMID 17712222 DOI: 10.1093/Ilar.48.4.356  0.721
2007 Kompoliti K, Chu Y, Shannon KM, Kordower JH. Neuropathological study 16 years after autologous adrenal medullary transplantation in a Parkinson's disease patient. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 1630-3. PMID 17534949 DOI: 10.1002/Mds.21528  0.381
2007 Gasmi M, Brandon EP, Herzog CD, Wilson A, Bishop KM, Hofer EK, Cunningham JJ, Printz MA, Kordower JH, Bartus RT. AAV2-mediated delivery of human neurturin to the rat nigrostriatal system: long-term efficacy and tolerability of CERE-120 for Parkinson's disease. Neurobiology of Disease. 27: 67-76. PMID 17532642 DOI: 10.1016/J.Nbd.2007.04.003  0.781
2007 Ramaswamy S, Shannon KM, Kordower JH. Huntington's disease: pathological mechanisms and therapeutic strategies. Cell Transplantation. 16: 301-12. PMID 17503740 DOI: 10.3727/000000007783464687  0.665
2007 Herzog CD, Dass B, Holden JE, Stansell J, Gasmi M, Tuszynski MH, Bartus RT, Kordower JH. Striatal delivery of CERE-120, an AAV2 vector encoding human neurturin, enhances activity of the dopaminergic nigrostriatal system in aged monkeys. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 1124-32. PMID 17443702 DOI: 10.1002/Mds.21503  0.466
2007 Kanaan NM, Kordower JH, Collier TJ. Age-related accumulation of Marinesco bodies and lipofuscin in rhesus monkey midbrain dopamine neurons: relevance to selective neuronal vulnerability. The Journal of Comparative Neurology. 502: 683-700. PMID 17436290 DOI: 10.1002/Cne.21428  0.42
2007 Marchionini DM, Lehrmann E, Chu Y, He B, Sortwell CE, Becker KG, Freed WJ, Kordower JH, Collier TJ. Role of heparin binding growth factors in nigrostriatal dopamine system development and Parkinson's disease. Brain Research. 1147: 77-88. PMID 17368428 DOI: 10.1016/J.Brainres.2007.02.028  0.4
2007 Ramaswamy S, McBride JL, Herzog CD, Brandon E, Gasmi M, Bartus RT, Kordower JH. Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease. Neurobiology of Disease. 26: 375-84. PMID 17336076 DOI: 10.1016/J.Nbd.2007.01.003  0.815
2007 Collier TJ, Lipton J, Daley BF, Palfi S, Chu Y, Sortwell C, Bakay RA, Sladek JR, Kordower JH. Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to parkinsonism. Neurobiology of Disease. 26: 56-65. PMID 17254792 DOI: 10.1016/J.Nbd.2006.11.013  0.367
2007 Chu Y, Kordower JH. Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease? Neurobiology of Disease. 25: 134-49. PMID 17055279 DOI: 10.1016/J.Nbd.2006.08.021  0.391
2006 Kordower JH, Herzog CD, Dass B, Bakay RA, Stansell J, Gasmi M, Bartus RT. Delivery of neurturin by AAV2 (CERE-120)-mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTP-treated monkeys. Annals of Neurology. 60: 706-15. PMID 17192932 DOI: 10.1002/Ana.21032  0.465
2006 Bové J, Zhou C, Jackson-Lewis V, Taylor J, Chu Y, Rideout HJ, Wu DC, Kordower JH, Petrucelli L, Przedborski S. Proteasome inhibition and Parkinson's disease modeling. Annals of Neurology. 60: 260-4. PMID 16862585 DOI: 10.1002/Ana.20937  0.383
2006 Kordower JH, Kanaan NM, Chu Y, Suresh Babu R, Stansell J, Terpstra BT, Sortwell CE, Steece-Collier K, Collier TJ. Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys. Annals of Neurology. 60: 264-8. PMID 16862579 DOI: 10.1002/Ana.20935  0.425
2006 Emerich DF, Thanos CG, Goddard M, Skinner SJ, Geany MS, Bell WJ, Bintz B, Schneider P, Chu Y, Babu RS, Borlongan CV, Boekelheide K, Hall S, Bryant B, Kordower JH. Extensive neuroprotection by choroid plexus transplants in excitotoxin lesioned monkeys. Neurobiology of Disease. 23: 471-80. PMID 16777422 DOI: 10.1016/J.Nbd.2006.04.014  0.434
2006 Emborg ME, Moirano J, Schafernak KT, Moirano M, Evans M, Konecny T, Roitberg B, Ambarish P, Mangubat E, Ma Y, Eidelberg D, Holden J, Kordower JH, Leestma JE. Basal ganglia lesions after MPTP administration in rhesus monkeys. Neurobiology of Disease. 23: 281-9. PMID 16766201 DOI: 10.1016/J.Nbd.2006.03.010  0.363
2006 McBride JL, Ramaswamy S, Gasmi M, Bartus RT, Herzog CD, Brandon EP, Zhou L, Pitzer MR, Berry-Kravis EM, Kordower JH. Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease. Proceedings of the National Academy of Sciences of the United States of America. 103: 9345-50. PMID 16751280 DOI: 10.1073/Pnas.0508875103  0.82
2006 Soderstrom K, O'Malley J, Steece-Collier K, Kordower JH. Neural repair strategies for Parkinson's disease: insights from primate models. Cell Transplantation. 15: 251-65. PMID 16719060 DOI: 10.3727/000000006783982025  0.429
2006 Dass B, Olanow CW, Kordower JH. Gene transfer of trophic factors and stem cell grafting as treatments for Parkinson's disease. Neurology. 66: S89-103. PMID 16717256 DOI: 10.1212/Wnl.66.10_Suppl_4.S89  0.467
2006 Schneider JA, Li JL, Li Y, Wilson RS, Kordower JH, Bennett DA. Substantia nigra tangles are related to gait impairment in older persons. Annals of Neurology. 59: 166-73. PMID 16374822 DOI: 10.1002/Ana.20723  0.338
2006 Behrstock S, Ebert A, McHugh J, Vosberg S, Moore J, Schneider B, Capowski E, Hei D, Kordower J, Aebischer P, Svendsen CN. Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates. Gene Therapy. 13: 379-88. PMID 16355116 DOI: 10.1038/Sj.Gt.3302679  0.437
2006 Chu Y, Le W, Kompoliti K, Jankovic J, Mufson EJ, Kordower JH. Nurr1 in Parkinson's disease and related disorders. The Journal of Comparative Neurology. 494: 495-514. PMID 16320253 DOI: 10.1002/Cne.20828  0.484
2006 Maries E, Kordower JH, Chu Y, Collier TJ, Sortwell CE, Olaru E, Shannon K, Steece-Collier K. Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats. Neurobiology of Disease. 21: 165-80. PMID 16095907 DOI: 10.1016/J.Nbd.2005.07.002  0.422
2006 Dass B, Kladis T, Chu Y, Kordower JH. RET expression does not change with age in the substantia nigra pars compacta of rhesus monkeys. Neurobiology of Aging. 27: 857-61. PMID 15950322 DOI: 10.1016/J.Neurobiolaging.2005.04.002  0.417
2006 Terpstra B, Collier T, Kanaan N, Levine N, Wohlgenant S, Kordower J, Sortwell C. Re-evaluation of systemic proteasome inhibition as an animal model for Parkinson's disease Experimental Neurology. 198: 590-591. DOI: 10.1016/J.Expneurol.2006.02.096  0.381
2006 Ramaswamy S, McBride J, Bartus R, Herzog C, Gasmi M, Brandon E, Zhou L, Berry-Kravis E, Kordower J. Gene therapy using AAV-neurturin (CERE-120) attenuates behavioral deficits and protects striatal neurons in models of Huntington's disease Experimental Neurology. 198: 586. DOI: 10.1016/J.Expneurol.2006.02.085  0.738
2006 Kordower J, Chu Y. Is age-related changes in alphasynuclein a good therapeutic target for PD Experimental Neurology. 198: 574. DOI: 10.1016/J.Expneurol.2006.02.057  0.331
2005 Counts SE, Chen EY, Ginsberg SD, Kordower JH, Mufson EJ. RNA amplification of bromodeoxyuridine labeled newborn neurons in the monkey hippocampus. Journal of Neuroscience Methods. 144: 197-201. PMID 15910978 DOI: 10.1016/J.Jneumeth.2004.11.005  0.334
2005 Tuszynski MH, Thal L, Pay M, Salmon DP, U HS, Bakay R, Patel P, Blesch A, Vahlsing HL, Ho G, Tong G, Potkin SG, Fallon J, Hansen L, Mufson EJ, ... Kordower JH, et al. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nature Medicine. 11: 551-5. PMID 15852017 DOI: 10.1038/Nm1239  0.373
2005 Collier TJ, Dung Ling Z, Carvey PM, Fletcher-Turner A, Yurek DM, Sladek JR, Kordower JH. Striatal trophic factor activity in aging monkeys with unilateral MPTP-induced parkinsonism. Experimental Neurology. 191: S60-7. PMID 15629762 DOI: 10.1016/J.Expneurol.2004.08.018  0.337
2004 Diprospero NA, Chen EY, Charles V, Plomann M, Kordower JH, Tagle DA. Early changes in Huntington's disease patient brains involve alterations in cytoskeletal and synaptic elements Journal of Neurocytology. 33: 517-533. PMID 15906159 DOI: 10.1007/S11068-004-0514-8  0.332
2004 Perez S, Sendera TJ, Kordower JH, Mufson EJ. Estrogen receptor alpha containing neurons in the monkey forebrain: lack of association with calcium binding proteins and choline acetyltransferase. Brain Research. 1019: 55-63. PMID 15306238 DOI: 10.1016/J.Brainres.2004.05.101  0.34
2004 McBride JL, Behrstock SP, Chen EY, Jakel RJ, Siegel I, Svendsen CN, Kordower JH. Human neural stem cell transplants improve motor function in a rat model of Huntington's disease. The Journal of Comparative Neurology. 475: 211-9. PMID 15211462 DOI: 10.1002/Cne.20176  0.614
2004 Kompoliti K, Chu Y, Polish A, Roberts J, McKay H, Mufson EJ, Leurgans S, Morrison JH, Kordower JH. Effects of estrogen replacement therapy on cholinergic basal forebrain neurons and cortical cholinergic innervation in young and aged ovariectomized rhesus monkeys. The Journal of Comparative Neurology. 472: 193-207. PMID 15048687 DOI: 10.1002/Cne.20050  0.342
2004 Herzog CD, Gasmi M, Cunningham JJ, Brandon EP, Ramirez A, Wilson A, Hofer EK, Hwang J, Manlapaz L, Kordower JH, Ostrove JM, Bartus RT. 227. Anatomical and Behavioral Effects of AAV2-Mediated Delivery of Neurturin to the Rat Striatum Prior to 6-Hydroxydopamine Induced Nigrostriatal Degeneration Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.172  0.784
2003 Collier TJ, Steece-Collier K, Kordower JH. Primate models of Parkinson's disease. Experimental Neurology. 183: 258-62. PMID 14552866 DOI: 10.1016/S0014-4886(03)00246-2  0.41
2003 Koprich JB, Chen EY, Kanaan NM, Campbell NG, Kordower JH, Lipton JW. Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) alters exploratory behavior, reduces monoamine metabolism, and increases forebrain tyrosine hydroxylase fiber density of juvenile rats. Neurotoxicology and Teratology. 25: 509-17. PMID 12972064 DOI: 10.1016/S0892-0362(03)00091-6  0.31
2003 Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, Sossi V, Brin MF, Shannon KM, Nauert GM, Perl DP, Godbold J, Freeman TB. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Annals of Neurology. 54: 403-14. PMID 12953276 DOI: 10.1002/Ana.10720  0.383
2003 Maries E, Dass B, Collier TJ, Kordower JH, Steece-Collier K. The role of alpha-synuclein in Parkinson's disease: insights from animal models. Nature Reviews. Neuroscience. 4: 727-38. PMID 12951565 DOI: 10.1038/Nrn1199  0.422
2003 Kus L, Borys E, Ping Chu Y, Ferguson SM, Blakely RD, Emborg ME, Kordower JH, Levey AI, Mufson EJ. Distribution of high affinity choline transporter immunoreactivity in the primate central nervous system. The Journal of Comparative Neurology. 463: 341-57. PMID 12820166 DOI: 10.1002/Cne.10759  0.326
2003 Hanbury R, Chen EY, Wuu J, Kordower JH. Knockout of p75NTR does not alter the viability of striatal neurons following a metabolic or excitotoxic injury. Journal of Molecular Neuroscience : Mn. 20: 93-102. PMID 12794303 DOI: 10.1385/Jmn:20:2:93  0.725
2003 McBride JL, During MJ, Wuu J, Chen EY, Leurgans SE, Kordower JH. Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF. Experimental Neurology. 181: 213-23. PMID 12781994 DOI: 10.1016/S0014-4886(03)00044-X  0.641
2003 Hanbury R, Ling ZD, Wuu J, Kordower JH. GFAP knockout mice have increased levels of GDNF that protect striatal neurons from metabolic and excitotoxic insults. The Journal of Comparative Neurology. 461: 307-16. PMID 12746870 DOI: 10.1002/Cne.10667  0.726
2003 Salzberg-Brenhouse HC, Chen EY, Emerich DF, Baldwin S, Hogeland K, Ranelli S, Lafreniere D, Perdomo B, Novak L, Kladis T, Fu K, Basile AS, Kordower JH, Bartus RT. Inhibitors of cyclooxygenase-2, but not cyclooxygenase-1 provide structural and functional protection against quinolinic acid-induced neurodegeneration. The Journal of Pharmacology and Experimental Therapeutics. 306: 218-28. PMID 12676885 DOI: 10.1124/Jpet.103.049700  0.345
2003 Kordower JH, Isacson, Brooks, Olanow, Hunot, Stocchi, Jenner, Rascol, Marek. In vivo gene delivery of glial cell line-derived neurotrophic factor for Parkinson's disease Annals of Neurology. 53. PMID 12666104 DOI: 10.1002/Ana.10485  0.477
2003 Roitberg B, Khan N, Tuccar E, Kompoliti K, Chu Y, Alperin N, Kordower JH, Emborg ME. Chronic ischemic stroke model in cynomolgus monkeys: behavioral, neuroimaging and anatomical study. Neurological Research. 25: 68-78. PMID 12564129 DOI: 10.1179/016164103101200950  0.349
2002 Eberling JL, Pivirotto P, Bringas J, Steiner JP, Kordower JH, Chu Y, Emborg ME, Bankiewicz KS. The immunophilin ligand GPI-1046 does not have neuroregenerative effects in MPTP-treated monkeys. Experimental Neurology. 178: 236-42. PMID 12504882 DOI: 10.1006/Exnr.2002.8023  0.413
2002 McBride JL, Kordower JH. Neuroprotection for Parkinson's disease using viral vector-mediated delivery of GDNF. Progress in Brain Research. 138: 421-32. PMID 12432782 DOI: 10.1016/S0079-6123(02)38091-9  0.625
2002 Steece-Collier K, Maries E, Kordower JH. Etiology of Parkinson's disease: Genetics and environment revisited Proceedings of the National Academy of Sciences of the United States of America. 99: 13972-13974. PMID 12391311 DOI: 10.1073/Pnas.242594999  0.466
2002 Chu Y, Kompoliti K, Cochran EJ, Mufson EJ, Kordower JH. Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra. The Journal of Comparative Neurology. 450: 203-14. PMID 12209851 DOI: 10.1002/Cne.10261  0.366
2002 Palfi S, Leventhal L, Chu Y, Ma SY, Emborg M, Bakay R, Déglon N, Hantraye P, Aebischer P, Kordower JH. Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 4942-54. PMID 12077191 DOI: 10.1523/Jneurosci.22-12-04942.2002  0.432
2002 Hanbury R, Charles V, Chen EY, Leventhal L, Rosenstein JM, Mufson EJ, Kordower JH. Excitotoxic and metabolic damage to the rodent striatum: role of the P75 neurotrophin receptor and glial progenitors. The Journal of Comparative Neurology. 444: 291-305. PMID 11891644 DOI: 10.1002/Cne.10104  0.706
2002 Roitberg BZ, Emborg ME, Sramek JG, Palfi S, Kordower JH. Behavioral and morphological comparison of two nonhuman primate models of Huntington's disease. Neurosurgery. 50: 137-45; discussion 1. PMID 11844244 DOI: 10.1097/00006123-200201000-00022  0.386
2002 Mufson EJ, Ma SY, Dills J, Cochran EJ, Leurgans S, Wuu J, Bennett DA, Jaffar S, Gilmor ML, Levey AI, Kordower JH. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. The Journal of Comparative Neurology. 443: 136-53. PMID 11793352 DOI: 10.1002/Cne.10122  0.363
2001 Guidetti P, Charles V, Chen EY, Reddy PH, Kordower JH, Whetsell WO, Schwarcz R, Tagle DA. Early degenerative changes in transgenic mice expressing mutant huntingtin involve dendritic abnormalities but no impairment of mitochondrial energy production. Experimental Neurology. 169: 340-50. PMID 11358447 DOI: 10.1006/Exnr.2000.7626  0.36
2001 Kordower JH, Aebischer P. Gene therapy to the rescue in Parkinson's disease: Response from Kordower and Aebischer Trends in Pharmacological Sciences. 22: 105-106. PMID 11239562 DOI: 10.1016/S0165-6147(00)01637-0  0.381
2001 Kordower JH, Chu Y, Stebbins GT, DeKosky ST, Cochran EJ, Bennett D, Mufson EJ. Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Annals of Neurology. 49: 202-13. PMID 11220740 DOI: 10.1002/1531-8249(20010201)49:2<202::Aid-Ana40>3.0.Co;2-3  0.325
2001 Emborg ME, Shin P, Roitberg B, Sramek JG, Chu Y, Stebbins GT, Hamilton JS, Suzdak PD, Steiner JP, Kordower JH. Systemic administration of the immunophilin ligand GPI 1046 in MPTP-treated monkeys Experimental Neurology. 168: 171-182. PMID 11170732 DOI: 10.1006/Exnr.2000.7592  0.398
2001 Emborg ME, Deglon N, Leventhal L, Aebischer P, Kordower JH. Viral vector-mediated gene therapy for Parkinson's disease Clinical Neuroscience Research. 1: 496-506. DOI: 10.1016/S1566-2772(01)00027-5  0.456
2000 Kordower JH, Isacson O, Leventhal L, Emerich DF. Cellular delivery of trophic factors for the treatment of Huntington's disease: is neuroprotection possible? Progress in Brain Research. 127: 414-30. PMID 11142039 DOI: 10.1016/S0079-6123(00)27020-9  0.355
2000 Kordower JH, Sortwell CE. Neuropathology of fetal nigra transplants for Parkinson's disease. Progress in Brain Research. 127: 333-44. PMID 11142034 DOI: 10.1016/S0079-6123(00)27016-7  0.421
2000 Freeman TB, Cicchetti F, Hauser RA, Deacon TW, Li XJ, Hersch SM, Nauert GM, Sanberg PR, Kordower JH, Saporta S, Isacson O. Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology. Proceedings of the National Academy of Sciences of the United States of America. 97: 13877-82. PMID 11106399 DOI: 10.1073/Pnas.97.25.13877  0.444
2000 Kordower JH, Emborg ME, Bloch J, Ma SY, Chu Y, Leventhal L, McBride J, Chen EY, Palfi S, Roitberg BZ, Brown WD, Holden JE, Pyzalski R, Taylor MD, Carvey P, et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science (New York, N.Y.). 290: 767-73. PMID 11052933 DOI: 10.1126/Science.290.5492.767  0.679
2000 Mufson EJ, Ma SY, Cochran EJ, Bennett DA, Beckett LA, Jaffar S, Saragovi HU, Kordower JH. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease. The Journal of Comparative Neurology. 427: 19-30. PMID 11042589 DOI: 10.1002/1096-9861(20001106)427:1<19::Aid-Cne2>3.0.Co;2-A  0.332
2000 Chen EY, Emerich DF, Bartus RT, Kordower JH. B2 bradykinin receptor immunoreactivity in rat brain. The Journal of Comparative Neurology. 427: 1-18. PMID 11042588 DOI: 10.1002/1096-9861(20001106)427:1<1::Aid-Cne1>3.0.Co;2-0  0.329
2000 Chen EY, Kallwitz E, Leff SE, Cochran EJ, Mufson EJ, Kordower JH, Mandel RJ. Age-related decreases in GTP-cyclohydrolase-I immunoreactive neurons in the monkey and human substantia nigra. The Journal of Comparative Neurology. 426: 534-48. PMID 11027397 DOI: 10.1002/1096-9861(20001030)426:4<534::Aid-Cne3>3.0.Co;2-G  0.356
2000 Leventhal L, Sortwell CE, Hanbury R, Collier TJ, Kordower JH, Palfi S. Cyclosporin A protects striatal neurons in vitro and in vivo from 3-nitropropionic acid toxicity. The Journal of Comparative Neurology. 425: 471-8. PMID 10975874 DOI: 10.1002/1096-9861(20001002)425:4<471::Aid-Cne1>3.0.Co;2-U  0.749
2000 Sendera TJ, Ma SY, Jaffar S, Kozlowski PB, Kordower JH, Mawal Y, Saragovi HU, Mufson EJ. Reduction in TrkA-immunoreactive neurons is not associated with an overexpression of galaninergic fibers within the nucleus basalis in Down's syndrome. Journal of Neurochemistry. 74: 1185-96. PMID 10693951 DOI: 10.1046/J.1471-4159.2000.741185.X  0.358
2000 Mufson EJ, Ma SY, Gilmor ML, Bennett DA, Beckett LA, Cochran EJ, Levey AI, Kordower JH. Cholinergic and neurotrophic markers within the nucleus basalis in elderly individuals with mild cognitive impairment and early Alzheimer's disease Neurobiology of Aging. 21: 270-271. DOI: 10.1016/S0197-4580(00)83170-X  0.304
1999 Kordower JH, Goetz CG. The first miracle in neurodegenerative disease: The discovery of oral levodopa Brain Research Bulletin. 50: 377-378. PMID 10643443 DOI: 10.1016/S0361-9230(99)00112-4  0.349
1999 Kordower JH, Bloch J, Ma SY, Chu Y, Palfi S, Roitberg BZ, Emborg M, Hantraye P, Déglon N, Aebischer P. Lentiviral gene transfer to the nonhuman primate brain. Experimental Neurology. 160: 1-16. PMID 10630186 DOI: 10.1006/Exnr.1999.7178  0.362
1999 Mufson EJ, Cai WJ, Jaffar S, Chen E, Stebbins G, Sendera T, Kordower JH. Estrogen receptor immunoreactivity within subregions of the rat forebrain: neuronal distribution and association with perikarya containing choline acetyltransferase. Brain Research. 849: 253-74. PMID 10592312 DOI: 10.1016/S0006-8993(99)01960-5  0.386
1999 Kordower JH, Isacson O, Emerich DF. Cellular delivery of trophic factors for the treatment of Huntington's disease: is neuroprotection possible? Experimental Neurology. 159: 4-20. PMID 10486171 DOI: 10.1006/Exnr.1999.7156  0.417
1999 Kordower JH, Palfi S, Chen EY, Ma SY, Sendera T, Cochran EJ, Cochran EJ, Mufson EJ, Penn R, Goetz CG, Comella CD. Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease. Annals of Neurology. 46: 419-24. PMID 10482276 DOI: 10.1002/1531-8249(199909)46:3<419::Aid-Ana21>3.0.Co;2-Q  0.453
1999 Ma SY, Ciliax BJ, Stebbins G, Jaffar S, Joyce JN, Cochran EJ, Kordower JH, Mash DC, Levey AI, Mufson EJ. Dopamine transporter-immunoreactive neurons decrease with age in the human substantia nigra. The Journal of Comparative Neurology. 409: 25-37. PMID 10363709 DOI: 10.1002/(Sici)1096-9861(19990621)409:1<25::Aid-Cne3>3.0.Co;2-E  0.351
1998 Mufson EJ, Kahl U, Bowser R, Mash DC, Kordower JH, Deecher DC. Galanin expression within the basal forebrain in Alzheimer's disease. Comments on therapeutic potential. Annals of the New York Academy of Sciences. 863: 291-304. PMID 9928179 DOI: 10.1111/J.1749-6632.1998.Tb10703.X  0.432
1998 Emborg ME, Ma SY, Mufson EJ, Levey AI, Taylor MD, Brown WD, Holden JE, Kordower JH. Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys. The Journal of Comparative Neurology. 401: 253-65. PMID 9822152 DOI: 10.1002/(Sici)1096-9861(19981116)401:2<253::Aid-Cne7>3.0.Co;2-X  0.388
1998 Granholm AC, Albeck D, Bäckman C, Curtis M, Ebendal T, Friden P, Henry M, Hoffer B, Kordower J, Rose GM, Söderström S, Bartus RT. A non-invasive system for delivering neural growth factors across the blood-brain barrier: a review. Reviews in the Neurosciences. 9: 31-55. PMID 9683326 DOI: 10.1515/Revneuro.1998.9.1.31  0.389
1998 Emerich DF, Bruhn S, Chu Y, Kordower JH. Cellular delivery of CNTF but not NT-4/5 prevents degeneration of striatal neurons in a rodent model of Huntington's disease. Cell Transplantation. 7: 213-25. PMID 9588602 DOI: 10.1016/S0963-6897(97)00163-2  0.46
1997 Carpenter MK, Winkler C, Fricker R, Emerich DF, Wong SC, Greco C, Chen EY, Chu Y, Kordower JH, Messing A, Björklund A, Hammang JP. Generation and transplantation of EGF-responsive neural stem cells derived from GFAP-hNGF transgenic mice. Experimental Neurology. 148: 187-204. PMID 9398461 DOI: 10.1006/Exnr.1997.6657  0.391
1997 Watts RL, Subramanian T, Freeman A, Goetz CG, Penn RD, Stebbins GT, Kordower JH, Bakay RA. Effect of stereotaxic intrastriatal cografts of autologous adrenal medulla and peripheral nerve in Parkinson's disease: two-year follow-up study. Experimental Neurology. 147: 510-7. PMID 9344575 DOI: 10.1006/Exnr.1997.6626  0.326
1997 Kordower JH, Chen EY, Winkler C, Fricker R, Charles V, Messing A, Mufson EJ, Wong SC, Rosenstein JM, Björklund A, Emerich DF, Hammang J, Carpenter MK. Grafts of EGF-responsive neural stem cells derived from GFAP-hNGF transgenic mice: trophic and tropic effects in a rodent model of Huntington's disease. The Journal of Comparative Neurology. 387: 96-113. PMID 9331174 DOI: 10.1002/(Sici)1096-9861(19971013)387:1<96::Aid-Cne8>3.0.Co;2-I  0.437
1997 Mufson EJ, Lavine N, Jaffar S, Kordower JH, Quirion R, Saragovi HU. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Experimental Neurology. 146: 91-103. PMID 9225742 DOI: 10.1006/Exnr.1997.6504  0.384
1997 Kordower JH, Styren S, Clarke M, DeKosky ST, Olanow CW, Freeman TB. Fetal grafting for Parkinson's disease: expression of immune markers in two patients with functional fetal nigral implants. Cell Transplantation. 6: 213-9. PMID 9171154 DOI: 10.1016/S0963-6897(97)00019-5  0.353
1997 Bowser R, Kordower JH, Mufson EJ. A confocal microscopic analysis of galaninergic hyperinnervation of cholinergic basal forebrain neurons in Alzheimer's disease. Brain Pathology (Zurich, Switzerland). 7: 723-30. PMID 9161723 DOI: 10.1111/J.1750-3639.1997.Tb01058.X  0.386
1997 Bresjanac M, Sagen J, Seigel G, Paino CL, Kordower J, Gash DM. Xenogeneic adrenal medulla graft rejection rather than survival leads to increased rat striatal tyrosine hydroxylase immunoreactivity. Journal of Neuropathology and Experimental Neurology. 56: 490-8. PMID 9143262 DOI: 10.1097/00005072-199705000-00005  0.323
1997 Kordower JH, Goetz CG, Freeman TB, Olanow CW. Dopaminergic transplants in patients with Parkinson's disease: neuroanatomical correlates of clinical recovery. Experimental Neurology. 144: 41-6. PMID 9126150 DOI: 10.1006/Exnr.1996.6386  0.417
1997 Emerich DF, Winn SR, Hantraye PM, Peschanski M, Chen EY, Chu Y, McDermott P, Baetge EE, Kordower JH. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease. Nature. 386: 395-9. PMID 9121555 DOI: 10.1038/386395A0  0.472
1997 Olanow CW, Kordower JH, Freeman TB. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends in Neurosciences. 19: 102-9. PMID 9054056 DOI: 10.1016/S0166-2236(96)80038-5  0.414
1997 Kordower JH, Maclennan AJ. Ciliary neurotrophic factor receptor alpha-immunoreactivity in the monkey central nervous system. The Journal of Comparative Neurology. 377: 365-80. PMID 8989652 DOI: 10.1002/(Sici)1096-9861(19970120)377:3<365::Aid-Cne5>3.0.Co;2-0  0.337
1996 Bartus RT, Dean RL, Abelleira S, Charles V, Kordower JH. Dissociation of p75 receptors and nerve growth factor neurotrophic effects: lack of p75 immunoreactivity in striatum following physical trauma, excitotoxicity and NGF administration. Restorative Neurology and Neuroscience. 10: 49-59. PMID 21551853 DOI: 10.3233/Rnn-1996-10107  0.32
1996 Charles V, Mufson EJ, Friden PM, Bartus RT, Kordower JH. Atrophy of cholinergic basal forebrain neurons following excitotoxic cortical lesions is reversed by intravenous administration of an NGF conjugate. Brain Research. 728: 193-203. PMID 8864482 DOI: 10.1016/0006-8993(96)00398-8  0.369
1996 Mufson EJ, Kroin JS, Liu YT, Sobreviela T, Penn RD, Miller JA, Kordower JH. Intrastriatal and intraventricular infusion of brain-derived neurotrophic factor in the cynomologous monkey: distribution, retrograde transport and co-localization with substantia nigra dopamine-containing neurons. Neuroscience. 71: 179-91. PMID 8834401 DOI: 10.1016/0306-4522(95)00431-9  0.354
1996 Kordower JH, Rosenstein JM, Collier TJ, Burke MA, Chen EY, Li JM, Martel L, Levey AE, Mufson EJ, Freeman TB, Olanow CW. Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies. The Journal of Comparative Neurology. 370: 203-30. PMID 8808731 DOI: 10.1002/(Sici)1096-9861(19960624)370:2<203::Aid-Cne6>3.0.Co;2-6  0.395
1996 Chen EY, Mufson EJ, Kordower JH. TRK and p75 neurotrophin receptor systems in the developing human brain. The Journal of Comparative Neurology. 369: 591-618. PMID 8761930 DOI: 10.1002/(Sici)1096-9861(19960610)369:4<591::Aid-Cne8>3.0.Co;2-#  0.369
1996 Emerich DF, Lindner MD, Winn SR, Chen EY, Frydel BR, Kordower JH. Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 5168-81. PMID 8756445 DOI: 10.1523/Jneurosci.16-16-05168.1996  0.434
1996 Kordower JH, Chen EY, Mufson EJ, Winn SR, Emerich DF. Intrastriatal implants of polymer encapsulated cells genetically modified to secrete human nerve growth factor: trophic effects upon cholinergic and noncholinergic striatal neurons. Neuroscience. 72: 63-77. PMID 8730706 DOI: 10.1016/0306-4522(95)00543-9  0.337
1996 Shannon KM, Kordower JH. Neural transplantation for Huntington's disease: Experimental rationale and recommendations for clinical trials Cell Transplantation. 5: 339-352. PMID 8689044 DOI: 10.1016/0963-6897(95)02052-7  0.431
1995 Hammang JP, Emerich DF, Winn SR, Lee A, Lindner MD, Gentile FT, Doherty EJ, Kordower JH, Baetge EE. Delivery of neurotrophic factors to the CNS using encapsulated cells: developing treatments for neurodegenerative diseases. Cell Transplantation. 4: S27-8. PMID 7795899 DOI: 10.1016/0963-6897(94)00069-V  0.361
1995 Kordower JH, Liu YT, Winn S, Emerich DF. Encapsulated PC12 cell transplants into hemiparkinsonian monkeys: a behavioral, neuroanatomical, and neurochemical analysis. Cell Transplantation. 4: 155-71. PMID 7773555 DOI: 10.1016/0963-6897(95)90031-4  0.35
1995 Schueler SB, Sagen J, Pappas GD, Kordower JH. Long-term viability of isolated bovine adrenal medullary chromaffin cells following intrastriatal transplantation. Cell Transplantation. 4: 55-64. PMID 7728334 DOI: 10.1016/0963-6897(94)00939-H  0.321
1995 Freeman TB, Sanberg PR, Nauert GM, Boss BD, Spector D, Olanow CW, Kordower JH. The influence of donor age on the survival of solid and suspension intraparenchymal human embryonic nigral grafts Cell Transplantation. 4: 141-154. PMID 7728329 DOI: 10.1016/0963-6897(94)00048-O  0.329
1995 Kordower JH, Freeman TB, Snow BJ, Vingerhoets FJ, Mufson EJ, Sanberg PR, Hauser RA, Smith DA, Nauert GM, Perl DP. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. The New England Journal of Medicine. 332: 1118-24. PMID 7700284 DOI: 10.1056/Nejm199504273321702  0.415
1995 Freeman TB, Olanow CW, Hauser RA, Nauert GM, Smith DA, Borlongan CV, Sanberg PR, Holt DA, Kordower JH, Vingerhoets FJ. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Annals of Neurology. 38: 379-88. PMID 7668823 DOI: 10.1002/Ana.410380307  0.387
1995 Mufson EJ, Conner JM, Kordower JH. Nerve growth factor in Alzheimer's disease: defective retrograde transport to nucleus basalis. Neuroreport. 6: 1063-6. PMID 7632896 DOI: 10.1097/00001756-199505090-00028  0.346
1994 Mufson EJ, Conner JM, Varon S, Kordower JH. Nerve growth factor-like immunoreactive profiles in the primate basal forebrain and hippocampal formation. The Journal of Comparative Neurology. 341: 507-19. PMID 8201026 DOI: 10.1002/Cne.903410407  0.335
1994 Kordower JH, Charles V, Bayer R, Bartus RT, Putney S, Walus LR, Friden PM. Intravenous administration of a transferrin receptor antibody-nerve growth factor conjugate prevents the degeneration of cholinergic striatal neurons in a model of Huntington disease. Proceedings of the National Academy of Sciences of the United States of America. 91: 9077-80. PMID 8090772 DOI: 10.1073/Pnas.91.19.9077  0.392
1994 Kordower JH, Winn SR, Liu YT, Mufson EJ, Sladek JR, Hammang JP, Baetge EE, Emerich DF. The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor. Proceedings of the National Academy of Sciences of the United States of America. 91: 10898-902. PMID 7971980 DOI: 10.1073/Pnas.91.23.10898  0.404
1994 Sobreviela T, Clary DO, Reichardt LF, Brandabur MM, Kordower JH, Mufson EJ. TrkA-immunoreactive profiles in the central nervous system: colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin. The Journal of Comparative Neurology. 350: 587-611. PMID 7890832 DOI: 10.1002/Cne.903500407  0.353
1994 Burke MA, Mobley WC, Cho J, Wiegand SJ, Lindsay RM, Mufson EJ, Kordower JH. Loss of developing cholinergic basal forebrain neurons following excitotoxic lesions of the hippocampus: rescue by neurotrophins. Experimental Neurology. 130: 178-95. PMID 7867749 DOI: 10.1006/Exnr.1994.1197  0.398
1994 Kordower JH, Chen EY, Sladek JR, Mufson EJ. trk-immunoreactivity in the monkey central nervous system: forebrain. The Journal of Comparative Neurology. 349: 20-35. PMID 7852624 DOI: 10.1002/Cne.903490103  0.389
1994 Emerich DF, Winn SR, Harper J, Hammang JP, Baetge EE, Kordower JH. Implants of polymer-encapsulated human NGF-secreting cells in the nonhuman primate: rescue and sprouting of degenerating cholinergic basal forebrain neurons. The Journal of Comparative Neurology. 349: 148-64. PMID 7852623 DOI: 10.1002/Cne.903490110  0.39
1994 Mufson EJ, Kroin JS, Sobreviela T, Burke MA, Kordower JH, Penn RD, Miller JA. Intrastriatal infusions of brain-derived neurotrophic factor: retrograde transport and colocalization with dopamine containing substantia nigra neurons in rat. Experimental Neurology. 129: 15-26. PMID 7523178 DOI: 10.1006/Exnr.1994.1143  0.392
1994 Burke MA, Apter JR, Wainer BH, Mufson EJ, Kordower JH. Age-related vulnerability of developing cholinergic basal forebrain neurons following excitotoxic lesions of the hippocampus. Experimental Neurology. 128: 159-71. PMID 7521302 DOI: 10.1006/Exnr.1994.1124  0.39
1994 Anton R, Kordower JH, Maidment NT, Manaster JS, Kane DJ, Rabizadeh S, Schueller SB, Yang J, Rabizadeh S, Edwards RH. Neural-targeted gene therapy for rodent and primate hemiparkinsonism. Experimental Neurology. 127: 207-18. PMID 7518394 DOI: 10.1006/Exnr.1994.1097  0.354
1994 Fiandaca MS, Kordower JH. Techniques in Adrenal Medullary Transplantation for Experimental Nonhuman Primate Parkinsonism Methods in Neurosciences. 21: 253-271. DOI: 10.1016/B978-0-12-185291-7.50021-7  0.424
1993 Kordower JH, Mufson EJ. NGF receptor (p75)-immunoreactivity in the developing primate basal ganglia. The Journal of Comparative Neurology. 327: 359-75. PMID 8440771 DOI: 10.1002/Cne.903270305  0.376
1993 Wainer BH, Steininger TL, Roback JD, Burke-Watson MA, Mufson EJ, Kordower J. Ascending cholinergic pathways: functional organization and implications for disease models. Progress in Brain Research. 98: 9-30. PMID 7902596 DOI: 10.1016/S0079-6123(08)62378-X  0.384
1993 Mufson EJ, Cochran E, Benzing W, Kordower JH. Galaninergic innervation of the cholinergic vertical limb of the diagonal band (Ch2) and bed nucleus of the stria terminalis in aging, Alzheimer's disease and Down's syndrome. Dementia (Basel, Switzerland). 4: 237-50. PMID 7505157 DOI: 10.1159/000107329  0.328
1993 Benzing WC, Kordower JH, Mufson EJ. Galanin immunoreactivity within the primate basal forebrain: evolutionary change between monkeys and apes. The Journal of Comparative Neurology. 336: 31-9. PMID 7504703 DOI: 10.1002/Cne.903360103  0.354
1992 Kordower JH, Bankiewicz KS, Mufson EJ. NGF receptor (p75)-immunoreactivity within hypoglossal motor neurons following axotomy in monkeys. Restorative Neurology and Neuroscience. 4: 411-7. PMID 21551675 DOI: 10.3233/Rnn-1992-4606  0.363
1992 del Cerro M, Kordower JH, Lazar E, Grover DA, del Cerro C. Photoreceptor differentiation in retinal xenografts of fetal monkey retina Brain Research. 574: 1-8. PMID 1638386 DOI: 10.1016/0006-8993(92)90792-8  0.304
1992 Kordower JH, Mufson EJ. Nerve growth factor receptor-immunoreactive neurons within the developing human cortex. The Journal of Comparative Neurology. 323: 25-41. PMID 1385492 DOI: 10.1002/Cne.903230104  0.343
1992 Kordower JH, Burke-Watson M, Roback JD, Wainer BH. Stability of septohippocampal neurons following excitotoxic lesions of the rat hippocampus. Experimental Neurology. 117: 1-16. PMID 1377634 DOI: 10.1016/0014-4886(92)90105-Y  0.364
1992 Mufson EJ, Kordower JH. Cortical neurons express nerve growth factor receptors in advanced age and Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America. 89: 569-73. PMID 1309947 DOI: 10.1073/Pnas.89.2.569  0.365
1991 Mufson EJ, Presley LN, Kordower JH. Nerve growth factor receptor immunoreactivity within the nucleus basalis (Ch4) in Parkinson's disease: reduced cell numbers and co-localization with cholinergic neurons. Brain Research. 539: 19-30. PMID 1849779 DOI: 10.1016/0006-8993(91)90682-L  0.434
1991 Kordower JH, Cochran E, Penn RD, Goetz CG. Putative chromaffin cell survival and enhanced host-derived TH-fiber innervation following a functional adrenal medulla autograft for Parkinson's disease Annals of Neurology. 29: 405-412. PMID 1681779 DOI: 10.1002/Ana.410290411  0.398
1991 Freeman TB, Spence MS, Boss BD, Spector DH, Strecker RE, Olanow CW, Kordower JH. Development of dopaminergic neurons in the human substantia nigra. Experimental Neurology. 113: 344-53. PMID 1680741 DOI: 10.1016/0014-4886(91)90025-8  0.405
1991 Mufson EJ, Higgins GA, Kordower JH. Nerve growth factor receptor immunoreactivity in the new world monkey (Cebus apella) and human cerebellum. The Journal of Comparative Neurology. 308: 555-75. PMID 1650799 DOI: 10.1002/Cne.903080405  0.31
1989 Hansen JT, Bing G, Notter MFD, Kordower JH, Fiandaca MS, Gash DM. Adrenal chromaffin cells as transplants in animal models of Parkinson's disease Journal of Electron Microscopy Technique. 12: 308-315. PMID 2671302 DOI: 10.1002/Jemt.1060120403  0.301
Show low-probability matches.